These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30763582)

  • 1. Factors associated with provision of depot medroxyprogesterone acetate to adolescents by US health care providers.
    Ermias Y; Morgan IA; Curtis KM; Whiteman MK; Horton LG; Zapata LB
    Contraception; 2019 May; 99(5):300-305. PubMed ID: 30763582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health Care Provider Attitudes and Practices Related to 'Quick Start' Provision of Combined Hormonal Contraception and Depot Medroxyprogesterone Acetate to Adolescents.
    Morgan IA; Ermias Y; Zapata LB; Curtis KM; Whiteman MK
    J Adolesc Health; 2019 Feb; 64(2):211-218. PubMed ID: 30392865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interest in self-administration of subcutaneous depot medroxyprogesterone acetate in the United States.
    Upadhyay UD; Zlidar VM; Foster DG
    Contraception; 2016 Oct; 94(4):303-13. PubMed ID: 27326938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare Provider Attitudes Regarding Contraception for Women with Obesity.
    Jatlaoui TC; Zapata LB; Curtis KM; Folger SG; Marchbanks PA; Mandel MG; Jamieson DJ
    J Womens Health (Larchmt); 2017 Aug; 26(8):870-877. PubMed ID: 28140761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An implementation project to expand access to self-administered depot medroxyprogesterone acetate (DMPA).
    Katz M; Newmark RL; Aronstam A; O'Grady N; Strome S; Rafie S; Karlin J
    Contraception; 2020 Dec; 102(6):392-395. PubMed ID: 32931811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health Care Provider Attitudes Toward Safety of Selected Hormonal Contraceptives in Breastfeeding Women.
    Mayhew A; Ermias Y; Zapata LB; Pagano HP; Tepper NK
    Matern Child Health J; 2019 Aug; 23(8):1079-1086. PubMed ID: 31069600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in US health care provider attitudes related to contraceptive safety before and after the release of National Guidance.
    Zapata LB; Morgan IA; Curtis KM; Folger SG; Whiteman MK
    Contraception; 2019 Nov; 100(5):413-419. PubMed ID: 31369735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction of Community-Based Provision of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in Benin: Programmatic Results.
    Okegbe T; Affo J; Djihoun F; Zannou A; Hounyo O; Ahounou G; Bangbola KA; Harris N
    Glob Health Sci Pract; 2019 Jun; 7(2):228-239. PubMed ID: 31171559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuation of self-injected versus provider-administered contraception in Senegal: a nonrandomized, prospective cohort study.
    Cover J; Ba M; Drake JK; NDiaye MD
    Contraception; 2019 Feb; 99(2):137-141. PubMed ID: 30439358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Provision of DMPA-SC for self-administration in different practice settings during the COVID-19 pandemic: Data from providers across the United States.
    Comfort AB; Alvarez A; Goodman S; Upadhyay U; Mengesha B; Karlin J; Shokat M; Blum M; Harper CC
    Contraception; 2024 Mar; 131():110360. PubMed ID: 38158075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ugandan providers' views on the acceptability of contraceptive self-injection for adolescents: a qualitative study.
    Cover J; Namagembe A; Tumusiime J; Lim J; Cox CM
    Reprod Health; 2018 Oct; 15(1):165. PubMed ID: 30285779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Affecting Continued Use of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC): A Secondary Analysis of a 1-Year Randomized Trial in Malawi.
    Burke HM; Chen M; Buluzi M; Fuchs R; Wevill S; Venkatasubramanian L; Santo LD; Ngwira B
    Glob Health Sci Pract; 2019 Mar; 7(1):54-65. PubMed ID: 30894394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: a randomised controlled trial.
    Burke HM; Chen M; Buluzi M; Fuchs R; Wevill S; Venkatasubramanian L; Dal Santo L; Ngwira B
    Lancet Glob Health; 2018 May; 6(5):e568-e578. PubMed ID: 29526707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introducing the subcutaneous depot medroxyprogesterone acetate injectable contraceptive via social marketing: lessons learned from Nigeria's private sector.
    Liu J; Schatzkin E; Omoluabi E; Fajemisin M; Onuoha C; Erinfolami T; Ayodeji K; Ogunmola S; Shen J; Diamond-Smith N; Sieverding M
    Contraception; 2018 Nov; 98(5):438-448. PubMed ID: 30071196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of injectable progestin (medroxyprogesterone acetate) in adolescent health care.
    Isart F; Weber FT; Merrick CL; Rowe S
    Contraception; 1992 Jul; 46(1):41-8. PubMed ID: 1424622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception.
    Lei ZW; Wu SC; Garceau RJ; Jiang S; Yang QZ; Wang WL; Vander Meulen TC
    Contraception; 1996 Jun; 53(6):357-61. PubMed ID: 8773423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of depot medroxyprogesterone acetate contraception in adolescents.
    Davis AJ
    J Reprod Med; 1996 May; 41(5 Suppl):407-13. PubMed ID: 8725703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Provider acceptability of Sayana® Press: results from community health workers and clinic-based providers in Uganda and Senegal.
    Burke HM; Mueller MP; Packer C; Perry B; Bufumbo L; Mbengue D; Daff BM; Mbonye A
    Contraception; 2014 May; 89(5):368-73. PubMed ID: 24576792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Food and Drug Administration and medroxyprogesterone acetate. What are the issues?
    Rosenfield A; Maine D; Rochat R; Shelton J; Hatcher RA
    JAMA; 1983 Jun; 249(21):2922-8. PubMed ID: 6221125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health Care Provider Attitudes about the Safety of "Quick Start" Initiation of Long-Acting Reversible Contraception for Adolescents.
    Morgan IA; Zapata LB; Curtis KM; Whiteman MK
    J Pediatr Adolesc Gynecol; 2019 Aug; 32(4):402-408. PubMed ID: 30731216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.